STRATA Skin Sciences Gains Exclusivity Edge in Dermatology Market

STRATA Skin Sciences shares are trading higher after the company affirmed its patent portfolio provides market exclusivity for combination therapies of its XTRAC Excimer laser with JAK inhibitors and biologic drugs, promising expansion into new dermatologic indications like vitiligo.